News

Former FDA head Stephen Hahn joins radiopharmaceuticals startup as CEO

Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Scale Patient Access to Radiopharmaceutical Therapies

A New Theranostic System Designed for Radiopharma’s Real-World Demands

Facet Life Sciences Announces Partnership with Nucleus RadioPharma as Official Regulatory Partner

Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves

Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement

AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity

Nucleus RadioPharma Expands Radiopharmaceutical Research, Development and Manufacturing Capacity, Addressing Nationwide Supply Chain Constraints

Expanding Radiopharmaceuticals for Cancer Treatment: Addressing Supply and Manufacturing Challenges – Charles Conroy

Nucleus RadioPharma CEO Chuck Conroy featured In C&EN article: Investment grows in radiopharma manufacturing